Hi. What studies will be completed in 2021? do you know something about nor-urso? When will phase 3 be completed? when will it be available for us?
As I understand it preliminary reports this year in late April and the study to be completed by 2023. It is a European study (Austria) but there may well be an early access/compassionate use program. Their numbers look encouraging. It may well be worth contacting the study director:
Markus Pröls, PhD
Email: zentrale@drfalkpharma.de
and he may well be able to direct you to a CRO that could at leat get you registered or on mailing list.
TJ Mod Support
1 Like